Mark Charest, Portfolio Manager, joined New Leaf
Venture Partners in 2012. Previously, Mark was an Associate and
Kauffman Fellow at Panorama Capital where he served on the board of
Itero Biopharmaceuticals and was a board observer at Presidio
Pharmaceuticals and PowerVision. Mark joined Panorama from ZS
Associates, where he led consulting engagements for a variety of
global pharmaceutical companies focused on commercial strategy and
optimization. Mark gained early healthcare investing experience as
an Associate at Great Point Partners where he sourced and managed
capital allocations in public and private healthcare companies.
Prior to Great Point, Mark played a leadership role in several drug
discovery programs in the oncology area as a medicinal chemistry lab
manager at Novartis Institutes for BioMedical Research.